<SEC-DOCUMENT>0000950170-25-105185-index.html : 20250807
<SEC-HEADER>0000950170-25-105185.hdr.sgml : 20250807
<ACCEPTANCE-DATETIME>20250807165017
ACCESSION NUMBER:		0000950170-25-105185
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250805
FILED AS OF DATE:		20250807
DATE AS OF CHANGE:		20250807

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ellis Andrea
		CENTRAL INDEX KEY:			0001877680
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38959
		FILM NUMBER:		251195001

	MAIL ADDRESS:	
		STREET 1:		C/O BRIDGEBIO PHARMA, INC.
		STREET 2:		3160 PORTER DR., SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BridgeBio Pharma, Inc.
		CENTRAL INDEX KEY:			0001743881
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		(650) 391-9740

	MAIL ADDRESS:	
		STREET 1:		3160 PORTER DR.
		STREET 2:		SUITE 250
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BridgeBio Pharma LLC
		DATE OF NAME CHANGE:	20180618
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.DOCX
<SEQUENCE>2
<FILENAME>bbio-ex24_docx.htm
<DESCRIPTION>EX-24.DOCX
<TEXT>
Document 2 - file: bbio-ex24_docx.htm

</DOCUMENT>
</SEC-DOCUMENT>